[1] Goyal D, Limesand SW, Goyal R. Epigenetic responses and the developmental origins of health and disease[J]. J Endocrinol, 2019, 242(1):T105-T119. [2] Perera BPU, Faulk C, Svoboda LK, et al. The role of environmental exposures and the epigenome in health and disease[J]. Environ Mol Mutagen, 2020, 61(1):176-192. [3] Sekar D, Johnson J, Biruntha M, et al. Biological and clinical relevance of microRNAs in mitochondrial diseases/dysfunctions[J]. DNA Cell Biol, 2020, 39(8):1379-1384. [4] Yi YC, Chen XY, Zhang J,et al. Novel insights into the interplay between m6A modification and noncoding RNAs in cancer[J]. Mol Cancer, 2020, 19(1):121. [5] Ren WD, Lu JW, Huang MJ, et al. Structure and regulation of ZCCHC4 in m6A-methylation of 28S rRNA[J]. Nat Commun, 2019, 10(1):5042. [6] Zhang YL, Chen WJ, Zheng XW, et al. Regulatory role and mechanism of m6A RNA modification in human metabolic diseases[J]. Mol Ther Oncolytics, 2021, 22:52-63. [7] Chen XJ, Hua WF, Huang X, et al. Regulatory role of RNA N6-methyladenosine modification in bone biology and osteoporosis[J]. Front Endocrinol, 2020, 10:911. [8] Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation[J]. Nat Rev Mol Cell Biol, 2019, 20(10):608-624. [9] Wang P, Doxtader KA, Nam Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases[J]. Mol Cell, 2016, 63(2):306-317. [10] Wang X,Feng J, Xue Y, et al. Structural basis of N6-adenosine methylation by the METTL3-METTL14 complex[J]. Nature, 2016, 534(7608):575-578. [11] Schöller E, Weichmann F, Treiber T, et al. Interactions, localization, and phosphorylation of the m6A generating METTL3-METTL14-WTAP complex[J]. RNA, 2018, 24(4):499-512. [12] Yue YN, Liu J, Cui XL, et al. VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop Codon and associates with alternative polyadenylation[J]. Cell Discov, 2018, 4:10. [13] Knuckles P,Lence T, Haussmann IU, et al. Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)D[J]. Genes Dev, 2018, 32(5/6):415-429. [14] Wen J,Lv RT, Ma HH, et al. Zc3h13 regulates nuclear RNA m6A methylation and mouse embryonic stem cell self-renewal[J]. Mol Cell, 2018, 69(6):1028-1038.e6. [15] Bawankar P, Lence T, Paolantoni C, et al. Hakai is required for stabilization of core components of the m6A mRNA methylation machinery[J]. Nat Commun, 2021, 12(1):3778. [16] Pendleton KE, Chen BB, Liu KQ, et al. The U6 snRNA m6A methyltransferase METTL16 regulates SAM synthetase intron retention[J]. Cell, 2017, 169(5):824-835.e14. [17] Fu Y,Jia GF, Pang XQ, et al. FTO-mediated formation of N6-hydroxymethyladenosine and N6-formyladenosine in mammalian RNA[J]. Nat Commun, 2013, 4:1798. [18] Toh JDW, Crossley SWM, Bruemmer KJ, et al. Distinct RNA N-demethylation pathways catalyzed by nonheme iron ALKBH5 and FTO enzymes enable regulation of formaldehyde release rates[J]. Proc Natl Acad Sci USA, 2020, 117(41):25284-25292. [19] Zhang X, Wei LH, Wang YX, et al. Structural insights into FTO's catalytic mechanism for the demethylation of multiple RNA substrates[J]. Proc Natl Acad Sci USA, 2019, 116(8):2919-2924. [20] Mauer J, Luo XB, Blanjoie A, et al. Reversible methylation of m6A m in the 5' cap controls mRNA stability[J]. Nature, 2017, 541(7637):371-375. [21] Wang X, Zhao BS,Roundtree IA, et al. N6-methyladenosine modulates messenger RNA translation efficiency[J]. Cell, 2015, 161(6):1388-1399. [22] Wang X, Lu ZK, Gomez A, et al. N6-methyladenosine-dependent regulation of messenger RNA stability[J]. Nature, 2014, 505(7481):117-120. [23] Shi HL, Wang X, Lu ZK, et al. YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA[J]. Cell Res, 2017, 27(3):315-328. [24] Xiao W, Adhikari S, Dahal U, et al. Nuclear m6A reader YTHDC1 regulates mRNA splicing[J]. Mol Cell, 2016, 61(4):507-519. [25] Hsu PJ, Zhu YF, Ma HH, et al. Ythdc2 is an N6-methyladeno-sine binding protein that regulates mammalian spermatogenesis[J]. Cell Res, 2017, 27(9):1115-1127. [26] Meyer KD,Patil DP, Zhou J, et al. 5' UTR m6A promotes cap-independent translation[J]. Cell, 2015, 163(4):999-1010. [27] Choi J,Ieong KW, Demirci H, et al. N6-methyladenosine in mRNA disrupts tRNA selection and translation-elongation dynamics[J]. Nat Struct Mol Biol, 2016, 23(2):110-115. [28] Huang HL, Weng HY, Sun WJ, et al. Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation[J]. Nat Cell Biol, 2018, 20(3):285-295. [29] Liu N, Dai Q,Zheng GQ, et al. N6-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions[J]. Nature, 2015, 518(7540):560-564. [30] Liu N, Zhou KI,Parisien M, et al. N6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein[J]. Nucleic Acids Res, 2017, 45(10):6051-6063. [31] Wu BX, Su SC, Patil DP, et al. Molecular basis for the specific and multivariant recognitions of RNA substrates by human hnRNP A2/B1[J]. Nat Commun, 2018, 9(1):420. [32] Edupuganti RR, Geiger S, Lindeboom RGH, et al. N6-methyladenosine (m6A) recruits and repels proteins to regulate mRNA homeostasis[J]. Nat Struct Mol Biol, 2017, 24(10):870-878. [33] Zhang FR, Kang Y, Wang ML, et al. Fragile X mental retardation protein modulates the stability of its m6A-marked messenger RNA targets[J]. Hum Mol Genet, 2018, 27(22):3936-3950. [34] Tian C, Huang YL, Li QM, et al. Mettl3 regulates osteogenic differentiation and alternative splicing of vegfa in bone marrow mesenchymal stem cells[J]. Int J Mol Sci, 2019, 20(3):551. [35] Wu YS, Xie L, Wang MY, et al. Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis[J]. Nat Commun, 2018, 9(1):4772. [36] Yan GG, Yuan Y, He MY, et al. M6A methylation of precursor-miR-320/RUNX2 controls osteogenic potential of bone marrow-derived mesenchymal stem cells[J]. Mol Ther Nucleic Acids, 2020, 19:421-436. [37] Yu JJ, Shen LJ, Liu YL, et al. The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-κB signaling[J]. Mol Cell Biochem, 2020, 463(1/2):203-210. [38] Wang W,Qiao SC, Wu XB, et al. Circ_0008542 in osteoblast exosomes promotes osteoclast-induced bone resorption through m6A methylation[J]. Cell Death Dis, 2021, 12(7):628. [39] Chen J,Ning YC, Zhang H, et al. METTL14-dependent m6A regulates vascular calcification induced by indoxyl sulfate[J]. Life Sci, 2019, 239:117034. [40] Sun ZY, Wang H, Wang YX, et al. miR-103-3p targets the m6A methyltransferase METTL14 to inhibit osteoblastic bone formation[J]. Aging Cell, 2021, 20(2):e13298. [41] Zhang Q, Riddle RC, Yang Q,et al. The RNA demethylase FTO is required for maintenance of bone mass and functions to protect osteoblasts from genotoxic damage[J]. Proc Natl Acad Sci USA, 2019, 116(36):17980-17989. [42] Chen LS, Zhang M, Chen P,et al. The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG[J]. Acta Pharmacol Sin, 2022,43(5):1311-1323. [43] Shen GS, Zhou HB, Zhang H, et al. The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(12):3644-3654. [44] Wang J, Fu Q, Yang J,et al. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation[J]. Aging, 2021, 13(17):21134-21141. [45] Wang HF,Kuang MJ, Han SJ, et al. BMP2 modified by the m6A demethylation enzyme ALKBH5 in the ossification of the ligamentum flavum through the AKT signaling pathway[J]. Calcif Tissue Int, 2020, 106(5):486-493. [46] Feng LL, Fan YS, Zhou JJ, et al. The RNA demethylase ALKBH5 promotes osteoblast differentiation by modulating Runx2 mRNA stability[J]. FEBS Lett, 2021, 595(15):2007-2014. [47] Li ZF, Wang P, Li JT, et al. The N6-methyladenosine demethylase ALKBH5 negatively regulates the osteogenic differentiation of mesenchymal stem cells through PRMT6[J]. Cell Death Dis, 2021, 12(6):578. [48] Yu RQ, Li QM, Feng ZH, et al. m6A reader YTHDF2 regulates LPS-induced inflammatory response[J]. Int J Mol Sci, 2019, 20(6):1323. [49] Wang TT, He CQ. TNF-α and IL-6:The link between immune and bone system[J]. Curr Drug Targets, 2020, 21(3):213-227. [50] 文俊儒, 谭震, 林玮民,等. m6A结合蛋白YTHDC2对人骨髓间充质干细胞分化的影响[J]. 四川大学学报(医学版), 2021, 52(3):402. |